Apollo Commercial Real Estate Finance, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Apollo Commercial Real Estate Finance, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $271.59M | Feb 10, 2026 |
| FY2025 | Dec 31, 2024 | $303.67M | Feb 10, 2026 |
| FY2025 | Dec 31, 2023 | $344.59M | Feb 10, 2026 |
| FY2024 | Dec 31, 2022 | $303.64M | Feb 10, 2025 |
| FY2023 | Dec 31, 2021 | $284.51M | Feb 6, 2024 |
| FY2022 | Dec 31, 2020 | $278.68M | Feb 8, 2023 |
| FY2021 | Dec 31, 2019 | $334.48M | Feb 8, 2022 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $126.72M | Feb 10, 2026 |
| FY2025 | Dec 31, 2024 | ($119.64M) | Feb 10, 2026 |
| FY2025 | Dec 31, 2023 | $58.13M | Feb 10, 2026 |
| FY2024 | Dec 31, 2022 | $265.23M | Feb 10, 2025 |
| FY2023 | Dec 31, 2021 | $223.52M | Feb 6, 2024 |
| FY2020 | Dec 31, 2020 | $36.68M | Feb 10, 2021 |
| FY2020 | Sep 30, 2020 | $49.34M | Feb 10, 2021 |
| FY2020 | Jun 30, 2020 | $60.20M | Feb 10, 2021 |
| FY2020 | Mar 31, 2020 | ($127.84M) | Feb 10, 2021 |
| FY2020 | Dec 31, 2019 | $71.90M | Feb 10, 2021 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $142.52M | Feb 10, 2026 |
| FY2025 | Dec 31, 2024 | $200.26M | Feb 10, 2026 |
| FY2025 | Dec 31, 2023 | $273.86M | Feb 10, 2026 |
| FY2024 | Dec 31, 2022 | $267.71M | Feb 10, 2025 |
| FY2023 | Dec 31, 2021 | $199.38M | Feb 6, 2024 |
| FY2022 | Dec 31, 2020 | $164.05M | Feb 8, 2023 |
| FY2021 | Dec 31, 2019 | $273.44M | Feb 8, 2022 |
| FY2020 | Dec 31, 2018 | $265.96M | Feb 10, 2021 |
| FY2019 | Dec 31, 2017 | $154.87M | Feb 13, 2020 |
| FY2018 | Dec 31, 2016 | $123.89M | Feb 13, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $9.90B | Feb 10, 2026 |
| FY2025 | Dec 31, 2024 | $8.41B | Feb 10, 2026 |
| FY2024 | Dec 31, 2023 | $9.30B | Feb 10, 2025 |
| FY2023 | Dec 31, 2022 | $9.57B | Feb 6, 2024 |
| FY2022 | Dec 31, 2021 | $8.42B | Feb 8, 2023 |
| FY2021 | Dec 31, 2020 | $6.94B | Feb 8, 2022 |
| FY2020 | Dec 31, 2019 | $6.89B | Feb 10, 2021 |
| FY2019 | Dec 31, 2018 | $5.10B | Feb 13, 2020 |
| FY2018 | Dec 31, 2017 | $4.09B | Feb 13, 2019 |
| FY2017 | Dec 31, 2016 | $3.48B | Feb 14, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $8.04B | Feb 10, 2026 |
| FY2025 | Dec 31, 2024 | $6.54B | Feb 10, 2026 |
| FY2024 | Dec 31, 2023 | $7.09B | Feb 10, 2025 |
| FY2023 | Dec 31, 2022 | $7.21B | Feb 6, 2024 |
| FY2022 | Dec 31, 2021 | $6.12B | Feb 8, 2023 |
| FY2021 | Dec 31, 2020 | $4.67B | Feb 8, 2022 |
| FY2020 | Dec 31, 2019 | $4.26B | Feb 10, 2021 |
| FY2019 | Dec 31, 2018 | $2.59B | Feb 13, 2020 |
| FY2018 | Dec 31, 2017 | $2.00B | Feb 13, 2019 |
| FY2017 | Dec 31, 2016 | $1.55B | Feb 14, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.86B | Feb 10, 2026 |
| FY2025 | Dec 31, 2024 | $1.87B | Feb 10, 2026 |
| FY2025 | Dec 31, 2023 | $2.21B | Feb 10, 2026 |
| FY2025 | Dec 31, 2022 | $2.35B | Feb 10, 2026 |
| FY2024 | Dec 31, 2021 | $2.29B | Feb 10, 2025 |
| FY2023 | Dec 31, 2020 | $2.27B | Feb 6, 2024 |
| FY2022 | Dec 31, 2019 | $2.63B | Feb 8, 2023 |
| FY2021 | Dec 31, 2018 | $2.51B | Feb 8, 2022 |
| FY2020 | Dec 31, 2017 | $2.09B | Feb 10, 2021 |
| FY2019 | Dec 31, 2016 | $1.93B | Feb 13, 2020 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($849.68M) | Feb 10, 2026 |
| FY2025 | Dec 31, 2024 | ($822.67M) | Feb 10, 2026 |
| FY2024 | Dec 31, 2023 | ($520.24M) | Feb 10, 2025 |
| FY2023 | Dec 31, 2022 | ($363.88M) | Feb 6, 2024 |
| FY2022 | Dec 31, 2021 | ($427.88M) | Feb 8, 2023 |
| FY2021 | Dec 31, 2020 | ($438.72M) | Feb 8, 2022 |
| FY2020 | Dec 31, 2019 | ($196.95M) | Feb 10, 2021 |
| FY2019 | Dec 31, 2018 | ($130.17M) | Feb 13, 2020 |
| FY2018 | Dec 31, 2017 | ($83.14M) | Feb 13, 2019 |
| FY2017 | Dec 31, 2016 | ($48.07M) | Feb 14, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $139.83M | Feb 10, 2026 |
| FY2025 | Dec 31, 2024 | $317.40M | Feb 10, 2026 |
| FY2024 | Dec 31, 2023 | $225.44M | Feb 10, 2025 |
| FY2023 | Dec 31, 2022 | $222.03M | Feb 6, 2024 |
| FY2022 | Dec 31, 2021 | $343.11M | Feb 8, 2023 |
| FY2021 | Dec 31, 2020 | $325.50M | Feb 8, 2022 |
| FY2020 | Dec 31, 2019 | $452.28M | Feb 10, 2021 |
| FY2019 | Dec 31, 2018 | $109.81M | Feb 13, 2020 |
| FY2018 | Dec 31, 2017 | $77.67M | Feb 13, 2019 |
| FY2018 | Sep 30, 2017 | $140.23M | Feb 13, 2019 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2012 | Dec 31, 2012 | $225.16M | Mar 1, 2013 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Feb 10, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Feb 10, 2026 |
| FY2025 | Dec 31, 2023 | 0 | Feb 10, 2026 |
| FY2024 | Dec 31, 2022 | 1 | Feb 10, 2025 |
| FY2023 | Dec 31, 2021 | 1 | Feb 6, 2024 |
| FY2020 | Dec 31, 2020 | 0 | Feb 10, 2021 |
| FY2020 | Sep 30, 2020 | 0 | Feb 10, 2021 |
| FY2020 | Jun 30, 2020 | 0 | Feb 10, 2021 |
| FY2020 | Mar 31, 2020 | 0 | Feb 10, 2021 |
| FY2020 | Dec 31, 2019 | 0 | Feb 10, 2021 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Feb 10, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Feb 10, 2026 |
| FY2025 | Dec 31, 2023 | 0 | Feb 10, 2026 |
| FY2024 | Dec 31, 2022 | 1 | Feb 10, 2025 |
| FY2023 | Dec 31, 2021 | 1 | Feb 6, 2024 |
| FY2020 | Dec 31, 2020 | 0 | Feb 10, 2021 |
| FY2020 | Sep 30, 2020 | 0 | Feb 10, 2021 |
| FY2020 | Jun 30, 2020 | 0 | Feb 10, 2021 |
| FY2020 | Mar 31, 2020 | 0 | Feb 10, 2021 |
| FY2020 | Dec 31, 2019 | 0 | Feb 10, 2021 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 138.94M | Feb 10, 2026 |
| FY2025 | Dec 31, 2024 | 138.17M | Feb 10, 2026 |
| FY2024 | Dec 31, 2023 | 141.36M | Feb 10, 2025 |
| FY2023 | Dec 31, 2022 | 140.60M | Feb 6, 2024 |
| FY2022 | Dec 31, 2021 | 139.89M | Feb 8, 2023 |
| FY2021 | Dec 31, 2020 | 139.30M | Feb 8, 2022 |
| FY2020 | Dec 31, 2019 | 153.54M | Feb 10, 2021 |
| FY2019 | Dec 31, 2018 | 133.85M | Feb 13, 2020 |
| FY2018 | Dec 31, 2017 | 107.12M | Feb 13, 2019 |
| FY2017 | Dec 31, 2016 | 91.42M | Feb 14, 2018 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $141.28M | Feb 10, 2026 |
| FY2025 | Dec 31, 2024 | $185.95M | Feb 10, 2026 |
| FY2025 | Dec 31, 2023 | $202.02M | Feb 10, 2026 |
| FY2024 | Dec 31, 2022 | $200.57M | Feb 10, 2025 |
| FY2023 | Dec 31, 2021 | $199.65M | Feb 6, 2024 |
| FY2022 | Dec 31, 2020 | $237.75M | Feb 8, 2023 |
| FY2021 | Dec 31, 2019 | $269.23M | Feb 8, 2022 |
| FY2020 | Dec 31, 2018 | $227.22M | Feb 10, 2021 |
| FY2019 | Dec 31, 2017 | $183.88M | Feb 13, 2020 |
| FY2018 | Dec 31, 2016 | $132.21M | Feb 13, 2019 |